Roivant Sciences (ROIV) Change in Accured Expenses (2020 - 2025)
Roivant Sciences' Change in Accured Expenses history spans 6 years, with the latest figure at $8.6 million for Q4 2025.
- For Q4 2025, Change in Accured Expenses rose 143.98% year-over-year to $8.6 million; the TTM value through Dec 2025 reached -$23.4 million, up 54.78%, while the annual FY2025 figure was -$10.1 million, 233.55% down from the prior year.
- Change in Accured Expenses reached $8.6 million in Q4 2025 per ROIV's latest filing, down from $12.5 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $37.6 million in Q3 2023 to a low of -$50.0 million in Q2 2023.
- Average Change in Accured Expenses over 5 years is -$450800.0, with a median of $5.7 million recorded in 2022.
- Peak YoY movement for Change in Accured Expenses: skyrocketed 281.76% in 2021, then plummeted 376.83% in 2023.
- A 5-year view of Change in Accured Expenses shows it stood at $35.6 million in 2021, then plummeted by 83.97% to $5.7 million in 2022, then plummeted by 376.83% to -$15.8 million in 2023, then dropped by 23.58% to -$19.5 million in 2024, then soared by 143.98% to $8.6 million in 2025.
- Per Business Quant, the three most recent readings for ROIV's Change in Accured Expenses are $8.6 million (Q4 2025), $12.5 million (Q3 2025), and -$25.0 million (Q2 2025).